NCT05159739

Genetic Susceptibility to Periprosthetic Joint Infections

Enrolling by Invitation
Not specifiedAges 18+Observational
University of Utah
~150 participants
Updated 2026-03-19 on ClinicalTrials.gov
What's tested:Blood Draw or Saliva/Cheek Cell Sample:

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Genotyping
Measured over DNA extraction and analysis will be performed immediately after collection of blood draw or saliva/cheek cell sample by a certified core lab
Total Joint Arthroplasty
Periprosthetic Joint Infections

NCT05159739

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Utah Orthopaedic Center

    Salt Lake City, Utahno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Jeremy Gililland, M.D. · PRINCIPAL_INVESTIGATOR · University of Utah

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Families/pedigrees which demonstrate a high-risk for PJI
Unaffected family members, up to 3rd degree

Exclusion

None
  • GenotypingDNA extraction and analysis will be performed immediately after collection of blood draw or saliva/cheek cell sample by a certified core lab

    Samples will undergo genetic testing to determine the presence or absence of potential candidate genes responsible for the increased incidence of PJI.